OnCo

Sign in to keep your watchlist

Your watched pages live in this browser. Sign in with an email link and OnCo keeps the same list on every device you use. Only your email address and your watchlist are stored.

Low-risk gestational trophoblastic neoplasia (FIGO score 0 to 6): lines of therapy

Cancer page →

5 standard-of-care settings across 3 lines and 1 biomarker subgroup. Rows come from the cancer page's standard of care; the grid places each on its line and subgroup.

LineAll comers
Screening, prevention and diagnosis1
Advanced, first line2
Other settings2

Screening, prevention and diagnosis

SubgroupSettingApproachProducts and trialsEvidence
All comersDiagnosis and stagingSerial hCG after molar evacuation; pelvic Doppler ultrasound and chest X-ray or CT; FIGO scoring; no biopsy needed.40

Advanced, first line

SubgroupSettingApproachProducts and trialsEvidence
All comersFirst lineSingle-agent methotrexate with folinic acid (eight-day regimen) or pulsed actinomycin D (GOG 174), continued until hCG normalises plus three consolidation cycles.94
All comersResistance to first agentSwitch to the alternative single agent if hCG is low; EMA-CO if hCG is high; avelumab or pembrolizumab as chemotherapy-sparing options (TROPHIMMUN).98

Other settings

SubgroupSettingApproachProducts and trialsEvidence
All comersSurgerySecond uterine evacuation in selected women with low hCG; hysterectomy for women who have completed their families or with uncontrolled bleeding.32
All comersFollow-uphCG monitoring for twelve months after remission, contraception during follow-up, and hCG after every future pregnancy.-

Lines and subgroups are parsed from the setting text of each standard-of-care row and can misclassify an unusual phrasing; the row’s own setting is always shown. Guideline chips reflect the NCCN category and ESMO-MCBS grade recorded on the cancer page, checked on its stated date. Not medical advice.